Preparation and characterization of antibody to galactosyl( α1 → 4)galactosyl( β1 → 4)glucosylceramide

Antiserum against galactosyl( α1 → 4)galactosyl( β1 → 4)glucosylceramide (globotriaosylceramide, Gb 3) was raised in rabbits by the administration of four weekly intramuscular injections of 1.5 mg of the purified glycolipid along with bovine serum albumin and Freund's complete adjuvant. AntiGb...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta Vol. 582; no. 2; pp. 283 - 294
Main Authors Clarke, J.T.R., Embil, J.A.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 18.01.1979
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Antiserum against galactosyl( α1 → 4)galactosyl( β1 → 4)glucosylceramide (globotriaosylceramide, Gb 3) was raised in rabbits by the administration of four weekly intramuscular injections of 1.5 mg of the purified glycolipid along with bovine serum albumin and Freund's complete adjuvant. AntiGb 3 activity was quantitated initially by immunoprecipitation employing Gb 3 mixed with 100-fold excess of lecithin and cholesterol (1 : 1 or 1 : 2, by wt.) as antigen. Subsequently, complement fixation tests done with antigen preparations containing Gb 3/lecithin/cholesterol (1 : 6 : 20, by wt.) showed antiGb 3 titres of up to 1 : 8192. Fractionation of the antiserum by BioGel A5m chromatography indicated the antibody was an IgM immunoglobulin. The partially purified antibody stimulated complement-dependent release of glucose from glucose-containing liposomes prepared with sphingomyelin/cholesterol/dicetylphosphate/Gb 3 (molar ratio, 100 : 75 : 11 : 1). The antibody crossreacted with the trisaccharide, Gal( α1 → 4)Gal( β1 → 4)Glc, but not with galactosylceramide, lactosylceramide, GM1 ganglioside, globotetraosylceramide, digalactosyldiglyceride or a number of low molecular weight saccharides.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0304-4165
0006-3002
1872-8006
DOI:10.1016/0304-4165(79)90391-X